Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Cancer Risk in a Nested Case-Control Study in North-East Thailand

  • Tungsrithong, Naowarat (Department of Epidemiology, Faculty of Public Health, Khon Kaen University) ;
  • Kasinpila, Chananya (Department of Epidemiology, Faculty of Public Health, Khon Kaen University) ;
  • Maneenin, Chanwit (Department of Anatomy, College of Medicine and Public Health, Ubon Ratchathani University) ;
  • Namujju, Proscovia B. (Tampere School of Public Health, University of Tampere) ;
  • Lehtinen, Matti (Tampere School of Public Health, University of Tampere) ;
  • Anttila, Ahti (Mass Screening Registry, Finnish Cancer Registry) ;
  • Promthet, Supannee (Department of Epidemiology, Faculty of Public Health, Khon Kaen University)
  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Cervical cancer continues to be an important public health problem in Thailand. While the high risk human papillomavirus (HPV) types have been established as the principle causative agent of both malignancies and the precursor lesions, cervical intraepithelial neoplasia (CIN), other factors may also be involved like other sexually transmitted diseases, as well as smoking. Chlamydia trachomatis is an obligate intracellular Gramnegative bacterium which has a tendency to cause chronic infection featuring inflammation and therefore might be expected to increase the risk of cervical cancer. In the present nested case-control study, 61 cases of cervical cancer and 288 matched controls with original serum samples were identified from the Khon Kaen Cohort, established in the North-East of Thailand, by linkage to the Khon Kaen population based cancer registry. C. trachomatis specific IgG antibodies at recruitment were measured by microimmunofluorescence and assessed for association with cervical cancer using STATA release10. No significant link was noted either with all cancers or after removal of adenocarcinomas. The results suggest no association between Chlamydia infection and cervical cancer development in North-East Thailand, but possible influencing factors must be considered in any future research on this topic.

Keywords

References

  1. Anttila T, Saikku P, Koskela P, et al (2001). Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA, 285, 47-51. https://doi.org/10.1001/jama.285.1.47
  2. Arnheim Dahlstrom L, Andersson K, Luostarinen T, et al (2011). Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev, 20, 2541-50. https://doi.org/10.1158/1055-9965.EPI-11-0761
  3. Au WW, Abdou-Salama S, Sierra-Torres CH, Al-Hendy A. (2007). Environmental risk factors for prevention and molecular intervention of cervical cancer. Int J Hyg Envir Hlth, 210, 671-8. https://doi.org/10.1016/j.ijheh.2006.10.003
  4. Bhatla N, Puri K, Joseph E, et al (2013). Association of Chlamydia trachomatis infection with human papillomavirus (HPV) and cervical intraepithelial neoplasia - a pilot study. Indian J Med Res, 137, 533-9.
  5. Calil LN, Igansi CN, Meurer L, Edelweiss MI, Bozzetti MC (2011). Chlamydia trachomatis and human papillomavirus coinfection: association with p16INK4a and Ki67 expression in biopsies of patients with pre-neoplastic and neoplastic lesions. Braz J Infect Dis, 15, 126-31. https://doi.org/10.1016/S1413-8670(11)70157-X
  6. Castle PE, Escoffery C, Schachter J, et al (2003). Chlamydia trachomatis, herpes simplex virus 2, and human T- cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients. Sex Transm Dis, 30, 575-80. https://doi.org/10.1097/00007435-200307000-00009
  7. Chumduri C, Gurumurthy RK, Zadora PK, Mi Y, Meyer TF. (2013). Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe, 13, 746-58. https://doi.org/10.1016/j.chom.2013.05.010
  8. da Silva Barros NK, Costa MC, Alves RR, et al (2012). Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil. J Med Virol, 84, 1143-50. https://doi.org/10.1002/jmv.23312
  9. de Abreu AL, Nogara PR, Souza RP, et al (2012). Molecular detection of HPV and Chlamydia trachomatis infections in Brazilian women with abnormal cervical cytology. Am J Trop Med Hyg, 87, 1149-51. https://doi.org/10.4269/ajtmh.2012.12-0287
  10. Deluca GD, Basiletti J, Schelover E, et al (2011). Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina. Braz J Infect Dis, 15, 567-72. https://doi.org/10.1016/S1413-8670(11)70252-5
  11. Farivar TN, Johari P (2012). Lack of association between Chlamydia trachomatis infection and cervical cancer--Taq Man realtime PCR assay findings. Asian Pac J Cancer Prev, 13, 3701-4. https://doi.org/10.7314/APJCP.2012.13.8.3701
  12. Golijow CD, Abba MC, Mouron SA, et al (2005). Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol, 96, 181-6. https://doi.org/10.1016/j.ygyno.2004.09.037
  13. Insinga RP, Perez G, Wheeler CM, et al (2011). Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev, 20, 287-96. https://doi.org/10.1158/1055-9965.EPI-10-0791
  14. Lazenby GB, Taylor PT, Badman BS, et al (2014). An association Between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clin Ther, 36, 38-45. https://doi.org/10.1016/j.clinthera.2013.11.009
  15. Lehtinen M, Ault KA, Lyytikainen E, et al (2011). Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect, 87, 372-6. https://doi.org/10.1136/sti.2010.044354
  16. Louie KS, de Sanjose S, Diaz M, et al. (2009) Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer, 100, 1191-7. https://doi.org/10.1038/sj.bjc.6604974
  17. Luostarinen T, Namujju PB, Merikukka M, et al (2013). Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study. Int J Cancer, 133, 1756-9. https://doi.org/10.1002/ijc.28173
  18. Madeleine MM, Anttila T, Schwartz SM, et al (2007). Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer, 120, 650-5. https://doi.org/10.1002/ijc.22325
  19. Mendoza L, Mongelos P, Paez M, et al (2013). Human papillomavirus and other genital infections in indigenous women from Paraguay: a cross-sectional analytical study. BMC Infect Dis, 13, 531. https://doi.org/10.1186/1471-2334-13-531
  20. Moodley M, Moodley J, Chetty R, Herrington CS. (2003) The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer, 13, 103-10. https://doi.org/10.1046/j.1525-1438.2003.13030.x
  21. Moscicki AB, Hills N, Shiboski S, et al (2001). Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA, 285, 2995-3002. https://doi.org/10.1001/jama.285.23.2995
  22. Natphopsuk S, Settheetham-Ishida W, Pientong C, et al (2013). Human papillomavirus genotypes and cervical cancer in northeast Thailand. Asian Pac J Cancer Prev, 14, 6961-4. https://doi.org/10.7314/APJCP.2013.14.11.6961
  23. Natphopsuk S, Settheetham-Ishida W, Sinawat S, et al (2012). Risk factors for cervical cancer in northeastern Thailand: detailed analyses of sexual and smoking behavior. Asian Pac J Cancer Prev, 13, 5489-95. https://doi.org/10.7314/APJCP.2012.13.11.5489
  24. Naucler P, Chen H-C, Persson K, et al (2007). Seroprevalence of human papillomavirus and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol, 88, 814e22. https://doi.org/10.1099/vir.0.82503-0
  25. Onel M, Kucucuk S, Tore G, Agacfidan A (2013). Investigation of Chlamydia trachomatis seropositivity in patients with cervical cancer. Mikrobiyol Bul, 47, 702-7. (in Turkish). https://doi.org/10.5578/mb.5559
  26. Peitsidis P, Kalmantis K, Peitsidou A, et al (2012). Chlamydial infection in female lower genital tract and its correlation with cervical smear abnormalities. Bratisl Lek Listy, 113, 357-60.
  27. Quint KD, de Koning MN, Geraets DT, Quint WG, Pirog EC (2009). Comprehensive analysis of human papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma. Gynecol Oncol, 114, 390-4. https://doi.org/10.1016/j.ygyno.2009.05.013
  28. Safaeian M, Quint K, Schiffman M, et al (2010). Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst, 102, 1794-804. https://doi.org/10.1093/jnci/djq436
  29. Seda J, Avellanet Y, Roca FJ, et al (2011). Risk factors for abnormal cervical cytology in pregnant women attending the high-risk obstetrics clinic at the University Hospital in San Juan, Puerto Rico. P R Health Sci J, 30, 14-7.
  30. Settheetham-Ishida W, Yuenyao P, Tassaneeyakul W, et al (2006). Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand. Asian Pac J Cancer Prev, 7, 113-8.
  31. Shew ML, Ermel AC, Weaver BA, et al (2013). Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance. J Infect Dis, 208, 1416-21. https://doi.org/10.1093/infdis/jit346
  32. Silins I, Ryd W, Strand A, et al (2005). Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer, 116, 110-5. https://doi.org/10.1002/ijc.20970
  33. Silva J, Cerqueira F, Ribeiro J, et al., (2013). Is Chlamydia trachomatis related to human papillomavirus infection in young women of southern European population? A selfsampling study. Arch Gynecol Obstet, 288, 627-33. https://doi.org/10.1007/s00404-013-2771-6
  34. Smith JS, Bosetti C, Munoz N, et al (2004). Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer, 111, 431-9. https://doi.org/10.1002/ijc.20257
  35. Swangvaree SS, Kongkaew P, Ngamkham J (2013). Frequency and type-distribution of human papillomavirus from paraffin-embedded blocks of high grade cervical intraepithelial neoplasia lesions in Thailand. Asian Pac J Cancer Prev, 14, 1023-6. https://doi.org/10.7314/APJCP.2013.14.2.1023
  36. Tavares MC, de Macedo JL, de Lima Junior SF, et al (2014). Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil. Mol Biol Rep, 41, 865-74. https://doi.org/10.1007/s11033-013-2927-2
  37. Wallin KL, Wiklund F, Luostarinen T, et al (2002). A populationbased prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer, 101, 371-4. https://doi.org/10.1002/ijc.10639
  38. Yetimalar H, Kasap B, Cukurova K, et al (2011). Cofactors in human papillomavirus infection and cervical carcinogenesis. Arch Gynecol Obstet, 285, 805-10.
  39. Zur Hausen H (1991). Human papillomaviruses in the pathogenesis of anogenital cancer. Virology, 184, 9-13. https://doi.org/10.1016/0042-6822(91)90816-T

Cited by

  1. Cervical Cancer Gene Therapy by Gene Loaded PEG-PLA Nanomedicine vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4915
  2. Update knowledge on cervical cancer incidence and prevalence in Asia vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3617
  3. Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer vol.95, pp.13, 2016, https://doi.org/10.1097/MD.0000000000003077